ContraFect Corp. (CFRX) NASDAQ
$0.05 - (-)
Market Cap: -
As of 12/05/23 12:00 AM EST. Market closed.
ContraFect Corp. (CFRX)
NASDAQ
$0.05
- (-)
Market Cap: -
As of 12/05/23 12:00 AM EST. Market closed.
Add to Portfolio
we are a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases, particularly those treated in hospital-based settings. due to drug-resistant and newly-emerging pathogens, infections in the hospital are already the fourth leading cause of death in the united states, following heart disease, cancer and stroke. we address multi-drug ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Roger Pomerantz
Address
28 Wells Ave Ste 3, New York, Yonkers, 10701-7045.
PRICE CHART FOR CONTRAFECT CORP
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.23
Previous Close
$0.05
Days Range
$0.05 - $0.06
52 week range
- - -
Volume
910,216
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
10,704,803
Open
$0.23
Previous Close
$0.05
Days Range
$0.05 - $0.06
52 week range
- - -
Volume
910,216
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
10,704,803
FINANCIAL STATEMENTS FOR CONTRAFECT CORP
LOADING...
INSIDER TRANSACTIONS FOR CONTRAFECT CORP
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Messinger Michael | Chief Financial Officer | Dec 13, 2019 | Buy | $0.37 | 5,000 | 1,850 | 19,091 | Dec 16, 2019, 06:28 AM |
Sucoff Cary | Director | Dec 13, 2019 | Buy | $0.39 | 50,000 | 19,500 | 62,000 | Dec 16, 2019, 06:26 AM |
Low David N. | Director | Dec 13, 2019 | Buy | $0.43 | 300,000 | 129,000 | 370,550 | Dec 16, 2019, 06:21 AM |
Fosun Industrial Co., Ltd | 10% Owner | Dec 04, 2018 | Sale | $2.04 | 600,000 | 1,224,000 | 7,900,000 | Dec 06, 2018, 04:53 PM |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 10% Owner | Dec 04, 2018 | Sale | $2.04 | 600,000 | 1,224,000 | 7,900,000 | Dec 06, 2018, 04:51 PM |
BLECH ISAAC | Director | Jul 25, 2017 | Buy | $1.24 | 16,000 | 19,840 | 16,000 | Jul 27, 2017, 04:29 PM |
Muntner Joshua B | SVP Business Development | Jul 25, 2017 | Buy | $1.24 | 2,000 | 2,480 | 2,000 | Jul 26, 2017, 04:52 PM |
Messinger Michael | SVP Finance | Jul 25, 2017 | Buy | $1.24 | 800 | 992 | 14,091 | Jul 26, 2017, 04:52 PM |
Cassino Cara M | Chief Medical Officer | Jul 25, 2017 | Buy | $1.24 | 8,000 | 9,920 | 8,000 | Jul 26, 2017, 04:51 PM |
Bogdanos Natalie | General Counsel | Jul 25, 2017 | Buy | $1.24 | 800 | 992 | 800 | Jul 26, 2017, 04:50 PM |
Sucoff Cary | Director | Jul 25, 2017 | Buy | $1.24 | 12,000 | 14,880 | 12,000 | Jul 26, 2017, 04:50 PM |
Ricciardi Lisa | Director | Jul 25, 2017 | Buy | $1.24 | 9,600 | 11,904 | 9,600 | Jul 26, 2017, 04:49 PM |
Pomerantz Roger | Director | Jul 25, 2017 | Buy | $1.24 | 800 | 992 | 800 | Jul 26, 2017, 04:48 PM |
OTTO MICHAEL J. | Director | Jul 25, 2017 | Buy | $1.24 | 8,000 | 9,920 | 8,000 | Jul 26, 2017, 04:47 PM |
Low David N. | Director | Jul 25, 2017 | Buy | $1.24 | 40,000 | 49,600 | 70,550 | Jul 26, 2017, 04:45 PM |
BARER SOL J | Director | Jul 25, 2017 | Buy | $1.24 | 40,000 | 49,600 | 815,933 | Jul 26, 2017, 04:44 PM |
GILMAN STEVEN C | CEO | Jul 25, 2017 | Buy | $1.24 | 800 | 992 | 20,800 | Jul 26, 2017, 04:42 PM |
GILMAN STEVEN C | CEO | Jul 27, 2016 | Buy | $2.48 | 20,000 | 49,600 | 20,000 | Jul 27, 2016, 05:18 PM |
Couto Daniel | SVP Manufacturing & Facilities | Nov 17, 2015 | Sale | $3.81 | 2,872 | 10,937 | 0 | Nov 18, 2015, 09:34 PM |
Couto Daniel | SVP Manufacturing & Facilities | Nov 03, 2015 | Sale | $4.23 | 2,867 | 12,135 | 2,872 | Nov 04, 2015, 04:38 PM |
Couto Daniel | SVP Manufacturing & Facilities | Oct 20, 2015 | Sale | $4.48 | 2,867 | 12,854 | 5,739 | Oct 22, 2015, 05:52 PM |
Couto Daniel | SVP Manufacturing & Facilities | Oct 06, 2015 | Sale | $4.11 | 2,867 | 11,782 | 8,606 | Oct 08, 2015, 04:43 PM |
Couto Daniel | SVP Manufacturing & Facilities | Sep 22, 2015 | Sale | $4.76 | 2,867 | 13,644 | 11,473 | Sep 23, 2015, 05:58 PM |
Couto Daniel | SVP Manufacturing & Facilities | Sep 22, 2015 | Sale | $4.76 | 2,867 | 13,644 | 10,773 | Sep 22, 2015, 06:17 PM |
Couto Daniel | SVP Manufacturing & Facilities | Sep 08, 2015 | Sale | $4.90 | 2,867 | 14,057 | 14,340 | Sep 10, 2015, 04:35 PM |
GREGORY JULIA P | CEO | Mar 02, 2015 | Buy | $4.61 | 11,778 | 54,297 | 50,283 | Mar 03, 2015, 09:35 PM |
Couto Daniel | SVP Manufacturing & Facilities | Sep 11, 2014 | Option Exercise | $4.00 | 17,207 | 68,828 | 17,207 | Oct 08, 2014, 02:22 PM |
GREGORY JULIA P | CEO | Sep 11, 2014 | Option Exercise | $4.00 | 29,946 | 119,784 | 38,505 | Oct 08, 2014, 02:21 PM |
Wittekind Michael G. | Chief Scientific Officer | Sep 11, 2014 | Option Exercise | $4.00 | 17,893 | 71,572 | 17,893 | Oct 08, 2014, 02:20 PM |
Messinger Michael | VP Finance | Sep 11, 2014 | Option Exercise | $4.00 | 13,291 | 53,164 | 13,291 | Oct 08, 2014, 02:19 PM |
Kappel Barry J. | SVP Business Development | Sep 11, 2014 | Option Exercise | $4.00 | 12,532 | 50,128 | 12,532 | Oct 08, 2014, 02:18 PM |
Huang David B. | Chief Medical Officer | Sep 11, 2014 | Option Exercise | $4.00 | 23,901 | 95,604 | 23,901 | Oct 08, 2014, 02:16 PM |
Dong Nancy | VP Controller | Sep 11, 2014 | Option Exercise | $4.00 | 6,287 | 25,148 | 15,161 | Oct 08, 2014, 02:15 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Messinger Michael | Chief Financial Officer | 12/13/2019 | 1,850 |
Sucoff Cary | Director | 12/13/2019 | 19,500 |
Low David N. | Director | 12/13/2019 | 129,000 |
Fosun Industrial Co., Ltd | 10% Owner | 12/04/2018 | 1,224,000 |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 10% Owner | 12/04/2018 | 1,224,000 |
BLECH ISAAC | Director | 07/25/2017 | 19,840 |
Muntner Joshua B | SVP Business Development | 07/25/2017 | 2,480 |
Messinger Michael | SVP Finance | 07/25/2017 | 992 |
Cassino Cara M | Chief Medical Officer | 07/25/2017 | 9,920 |
Bogdanos Natalie | General Counsel | 07/25/2017 | 992 |
Sucoff Cary | Director | 07/25/2017 | 14,880 |
Ricciardi Lisa | Director | 07/25/2017 | 11,904 |
Pomerantz Roger | Director | 07/25/2017 | 992 |
OTTO MICHAEL J. | Director | 07/25/2017 | 9,920 |
Low David N. | Director | 07/25/2017 | 49,600 |
BARER SOL J | Director | 07/25/2017 | 49,600 |
GILMAN STEVEN C | CEO | 07/25/2017 | 992 |
GILMAN STEVEN C | CEO | 07/27/2016 | 49,600 |
Couto Daniel | SVP Manufacturing & Facilities | 11/17/2015 | 10,937 |
Couto Daniel | SVP Manufacturing & Facilities | 11/03/2015 | 12,135 |
Couto Daniel | SVP Manufacturing & Facilities | 10/20/2015 | 12,854 |
Couto Daniel | SVP Manufacturing & Facilities | 10/06/2015 | 11,782 |
Couto Daniel | SVP Manufacturing & Facilities | 09/22/2015 | 13,644 |
Couto Daniel | SVP Manufacturing & Facilities | 09/22/2015 | 13,644 |
Couto Daniel | SVP Manufacturing & Facilities | 09/08/2015 | 14,057 |
GREGORY JULIA P | CEO | 03/02/2015 | 54,297 |
Couto Daniel | SVP Manufacturing & Facilities | 09/11/2014 | 68,828 |
GREGORY JULIA P | CEO | 09/11/2014 | 119,784 |
Wittekind Michael G. | Chief Scientific Officer | 09/11/2014 | 71,572 |
Messinger Michael | VP Finance | 09/11/2014 | 53,164 |
Kappel Barry J. | SVP Business Development | 09/11/2014 | 50,128 |
Huang David B. | Chief Medical Officer | 09/11/2014 | 95,604 |
Dong Nancy | VP Controller | 09/11/2014 | 25,148 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR CONTRAFECT CORP
LOADING...